ABOUT SYNEOS HEALTH

Syneos Health™ is the industry’s only true end-to-end, fully integrated biopharmaceutical solutions company.  At Syneos Health, all the disciplines involved in bringing new therapies to market, from clinical to commercial, work together to create customer success. Our unique Biopharmaceutical Acceleration Model delivers value across the small to mid-size to large customer continuum.

Biopharmaceutical Acceleration Model

It happens when clinical and commercial work hand-in-hand together. When the walls between disciplines come down and are replaced by the sharing of critical insights and data to optimize your success. When everyone in the company begins their work with the ultimate end in mind. Biopharmaceutical acceleration is changing the game and it’s happening here.

Faster processes, deeper insights, smoother systems and more actionable Real World Evidence are just some of the benefits Syneos Health and biopharmaceutical acceleration can bring to a marketplace that grows increasingly complex and competitive each day.

SOLUTIONS

Clinical Development Clinical Development

We certainly don’t have to tell you that every customer has unique clinical development needs. Our fit-for-purpose CRO solutions are tailored to your product and requirements. Whatever your needs, we can adopt new processes and technologies, diverse therapeutic expertise and access to commercial insights that can facilitate shorter and more efficient trials designed to improve the likelihood of regulatory and commercial success.

Commercialization Commercialization

At Syneos Health™, we are able to improve brand performance by leveraging data and insights, accumulated best practices and deep access to therapeutic expertise. Serving customers of all sizes, our CCO (Contract Commercial Organization) capabilities are the broadest and most robust in the industry delivering flexible, targeted, multi-channel programs designed to produce a higher likelihood of launch success. At the same time, our commercial and market insights along with proprietary data access can improve clinical trial design and accelerate patient recruitment. It's a powerful platform for the modern biopharmaceutical world.

Consulting Consulting

We offer advisory services that can address commercial strategy and planning, pricing and market access, medical affairs, and risk and program management. Syneos HealthTM consulting practitioners span the entire product development and delivery continuum, adding high-value counsel and recommendations that make for more successful clinical development and brand launch success.

CONTACT INFORMATION

Syneos Health

3201 Beechleaf Court Suite 600

Raleigh, NC 27604-1547

UNITED STATES

Phone: 919 876 9300

Fax: 919 876 9360

FEATURED ARTICLES

  • Improving Patient Recruitment Rates In Oncology Trials
    Improving Patient Recruitment Rates In Oncology Trials

    The percentage of oncology patients participating in clinical trials is remarkably low: 8.1 percent according to a recent meta-analysis. Read a new report from Syneos Health that shares how enrollment rates and study timelines can be vastly improved by understanding the patient pathway and working to meet patients where they are as they travel along it.  The report shares actionable insights for how to meet patients at the right point in their journey – from understanding the influence of emotional pathways of the patient to selecting and priming sites.

  • Caregivers - The Missing Link to Patient Centricity
    Caregivers - The Missing Link to Patient Centricity

    Caregivers are an integral part of the care team and are involved in everything from medication choice to adherence strategy. Yet, they’ve often been an afterthought for life sciences companies, even as the industry focuses on patient centricity.

  • Health Consumer Mindsets
    Health Consumer Mindsets

    How are consumers engaging with their healthcare in today’s environment and what drives engagement, and what hinders motivation or ability to engage? This study explores these questions.

  • 2019 Health Trend Ten eBook
    2019 Health Trend Ten eBook

    Life science leaders need ideas and insights to help them invest and act with confidence. Discover 10 macro trends shaping the healthcare industry in the year ahead. Download the 2019 Health Trend Ten eBook.

  • Evolution Of Parkinson’s Disease Trial Characteristics: 2005 - 2017
    Evolution Of Parkinson’s Disease Trial Characteristics: 2005 - 2017

    A longitudinal analysis of PD study characteristics provides a deeper understanding of clinical trials dynamics and demonstrate how research paradigms have been changing across the years.

  • The Importance Of Real World Evidence In Oncology
    The Importance Of Real World Evidence In Oncology

    There is a significant need to collect Real World Evidence (RWE) to demonstrate the benefit of these drugs in clinical practice which can then be used as the wrap around to demonstrate true clinical benefit and address all stakeholder needs.

  • Thinking Pragmatically About The Future Of Real World Evidence
    Thinking Pragmatically About The Future Of Real World Evidence

    Questions and concerns as the FDA prepares to develop and implement a program evaluating the potential use of Real World Evidence (RWE) for regulatory decisions.

  • Trends In Oncology Trial Terminations Due To Toxicity
    Trends In Oncology Trial Terminations Due To Toxicity

    Are studies focusing on elderly cancer patients at increased risk for discontinuation due to safety reasons, such as toxicity?

  • Understanding The Continuum Of Clinical Collaboration
    Understanding The Continuum Of Clinical Collaboration

    Vendor-selection processes are tilting toward finding as broad and deep a fit as possible, the better to capture the efficiencies from scale and repeatability that those moves are intended to deliver.

  • Regulatory Requirements For Medical Devices In China
    Regulatory Requirements For Medical Devices In China

    Successful regulatory approval requires a deep understanding of the regulations, process and technical standards, as well as an appropriate regulatory strategy.